HTBX - Heat Biologics - COVID play
HTBX
- Currently 2.46 (Friday close)
- 84M o/s, 79M float
- $20M cash - decent runway
- Due to release news on COVID this month: https://ir.heatbio.com/press-releases
- Jeff Wolf, CEO of Heat, commented, “We remain on track to complete design and development of our COVID-19 vaccine in July, and expect that our gp96/nCoV-2 expressing cell line will be available for clinical-grade manufacturing with our partner, Waisman Biomanufacturing, in early August. Given our progress to date, we remain encouraged by the potential of our unique vaccine to provide broad cellular T-cell and humoral protection against COVID-19, as well as possible future mutations or other coronaviruses.”
- I'd be interested in anything under $2.00, I saw this at 1.00 last Monday 🤦♂️
Login to join the discussion!
Comments
Maverick - 3 years ago
I only had a trading position in this one (small) today. It totally got away from me.
I had mentioned this one on the Weekly Discussion at 1.00 last week, but never did my homework. Boy that was costly.....
Anyways, just watching from the cheap seats on this one. Too expensive for me now, but I'll be looking for a pullback. Decent news pipeline....
I had mentioned this one on the Weekly Discussion at 1.00 last week, but never did my homework. Boy that was costly.....
Anyways, just watching from the cheap seats on this one. Too expensive for me now, but I'll be looking for a pullback. Decent news pipeline....
Biotech Swings 👨⚕️💉
| Created By: | Maverick |
| Created: | Jun 25, 2020 |
| Total Followers: | 5 |
| Follow | |
The strategy here is simple: take 3 to 60 day positions in biotechs that have upcoming catalysts (data readouts, approvals, etc).
Offerings are the major danger, so always be mindful of cash position of the company you're trading.
Offerings are the major danger, so always be mindful of cash position of the company you're trading.